← FDA Drug Approvals (Drugs@FDA)

FERRIC CARBOXYMALTOSE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN · Approved 2026-06-25

Drug application

FDA Application #

ANDA217769

Application type

Abbreviated New Drug Application (Generic)

Brand name

FERRIC CARBOXYMALTOSE

Generic name

Ferric Carboxymaltose

Active ingredients

FERRIC CARBOXYMALTOSE

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

MYLAN

First approval

2026-06-25

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown